Robert Walker (University of Otago)

Professor of Medicine, University of Otago Dunedin New Zealand
Consultant Nephrologist Southern District Health Board, Dunedin New Zealand

Cardiovascular risk factors in chronic kidney disease,
CKD in the Pacific
Hypertension
Mechanisms of chronic intersitial fibrosis
Drug pharmacokinetics in kidney disease and nephrotoxicity

Tungsanga S, Okpechi IG, Bianchi MEV, Chaturvedi S, Collister D, Crowshoe H, Rodriguez de Sosa GM, Galadanci HA, Hedin E, Ibrahaim KS, Jain AK, Noronha IL, Erickson RL, Hughes JT, Komenda P, Kulvichit W, Peocits-Fihlo R, Raphael KL, Shah VO, Tafuna'i’ M, Tait, C, Turner C, Walker C, Walker R, Woods C, Levin A, Bello AK. Global Kidney Health Across Indigenous Populations. Nature Nephrology Reviews. 22: 99 -121 (2026)
Au A, Mantik K, Bahadory F, Statjakis P, Guiney H, Erilch J, Walker R, Poulton R, Endre Z. Plasma arginine metabolites in health and chronic kidney disease. Nephrology Dialysis Transplantation. 2023; 38: 2767-2775.
Mehta PM, Gimenez G, Walker RJ, Slatter T.L Reduction of lithium induced interstitial fibrosis on co-administration with amiloride. Scientific Reports 12: 14598 (2022).
Badve S, Pascoe E, Tiku A, Boudville N, Brown F, Cass A, Clarke P, Dalbeth N, Day R, de Zoysa J, Douglas B ,Faull R, Harris D, Hawley C, Jones G, Kanellis J, Palmer S, Perkovic V, Rangan G, Reidlinger D, Robison L, Walker R, Walters G, Johnson D. Effect of allopurinol on the progression of chronic kidney disease (the CKD-FIX Study): a double-blind, randomised, placebo-controlled trial. New England Journal of Medicine 382: 2504-13 (2020).
Kuan I, Savage RL, Duffull SB, Walker RJ, Wright DFB. The association between metformin therapy and lactic acidosis. Drug Safety 42:1449-1469 (2019).